Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease

Inflammatory bowel disease (IBD) is a progressive and debilitating inflammatory disease of the gastrointestinal tract (GIT). Despite recent advances, precise treatment and noninvasive monitoring remain challenging.